Slide resources

HDL and Atherosclerosis

HDL and Atherosclerosis: an overview

HDL cholesterol and cardiovascular risk

Raising HDL cholesterol: therapeutic considerations

Key trials

ARBITER 6-HALTS

Oxford nicotinic acid trial

ARBITER 2 and 3 trials

HATS: HDL Atherosclerosis Treatment Study

VA-HIT

Coronary Drug Project

FATS: Familial Atherosclerosis Treatment Study

CLAS

Niacin-laropiprant

COMPELL

SEACOAST

ACCORD

AIM-HIGH

HPS2-THRIVE

ILLUMINATE

DEFINE

Dalcetrapib: 48-week trial

Resource Links

Societies

Guidelines